U.S. pharma giant copyright scrapped two experimental weight loss supplements last yr—a the moment-every day capsule, lotiglipron, because of elevated liver enzymes in addition to a two times-each day capsule, danuglipron, due to robust side effects—but CEO Albert Bourla has claimed the company is set to “Participate in and gain” from the b